- Home
- SHBI vs ITOS Comparison
SHBI vs ITOS Comparison
Compare SHBI & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHBI
- ITOS
- Stock Information
- Founded
- SHBI 1876
- ITOS 2011
- Country
- SHBI United States
- ITOS United States
- Employees
- SHBI N/A
- ITOS 173
- Industry
- SHBI Major Banks
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHBI Finance
- ITOS Health Care
- Exchange
- SHBI Nasdaq
- ITOS Nasdaq
- Market Cap
- SHBI 532.0M
- ITOS 450.9M
- IPO Year
- SHBI N/A
- ITOS 2020
- Fundamental
- Price
- SHBI $16.79
- ITOS $10.19
- Analyst Decision
- SHBI Buy
- ITOS Hold
- Analyst Count
- SHBI 1
- ITOS 6
- Target Price
- SHBI $20.00
- ITOS $10.40
- AVG Volume (30 Days)
- SHBI 123.0K
- ITOS 1.0M
- Earning Date
- SHBI 07-24-2025
- ITOS 08-06-2025
- Dividend Yield
- SHBI 3.03%
- ITOS N/A
- EPS Growth
- SHBI 169.45
- ITOS N/A
- EPS
- SHBI 1.61
- ITOS N/A
- Revenue
- SHBI $208,209,000.00
- ITOS N/A
- Revenue This Year
- SHBI N/A
- ITOS N/A
- Revenue Next Year
- SHBI $16.61
- ITOS N/A
- P/E Ratio
- SHBI $9.84
- ITOS N/A
- Revenue Growth
- SHBI 24.24
- ITOS 177.89
- 52 Week Low
- SHBI $11.47
- ITOS $4.80
- 52 Week High
- SHBI $17.61
- ITOS $18.01
- Technical
- Relative Strength Index (RSI)
- SHBI 64.59
- ITOS 60.66
- Support Level
- SHBI $15.80
- ITOS $10.10
- Resistance Level
- SHBI $16.09
- ITOS $10.22
- Average True Range (ATR)
- SHBI 0.39
- ITOS 0.04
- MACD
- SHBI 0.08
- ITOS -0.00
- Stochastic Oscillator
- SHBI 98.26
- ITOS 78.57
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.